abstract |
An isolated molecule, comprising: a first antigen binding domain and a second antigen binding domain, wherein the first antigen binding domain specifically binds CD8 and the second antigen binding domain specifically binds a T cell receptor (TCR) complex. In another aspect, the disclosure provides an isolated molecule, comprising: a first antigen binding domain, a second antigen binding domain and a third antigen binding domain, wherein the first antigen binding domain specifically binds CDS, the second antigen binding domain specifically binds a TCR complex, and the third antigen binding domain binds a third antigen. |